Cryo-Cell International Inc (CCEL)
8.31
-0.08
(-0.95%)
USD |
NYAM |
Apr 30, 16:00
8.25
-0.06
(-0.72%)
After-Hours: 20:00
Cryo-Cell International Enterprise Value: 76.90M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 76.90M |
| April 29, 2024 | 77.55M |
| April 26, 2024 | 78.04M |
| April 25, 2024 | 72.77M |
| April 24, 2024 | 73.34M |
| April 23, 2024 | 72.12M |
| April 22, 2024 | 73.74M |
| April 19, 2024 | 70.34M |
| April 18, 2024 | 69.28M |
| April 17, 2024 | 64.26M |
| April 16, 2024 | 63.85M |
| April 15, 2024 | 66.93M |
| April 12, 2024 | 69.07M |
| April 11, 2024 | 69.59M |
| April 10, 2024 | 71.14M |
| April 09, 2024 | 70.68M |
| April 08, 2024 | 71.47M |
| April 05, 2024 | 70.89M |
| April 04, 2024 | 70.23M |
| April 03, 2024 | 71.96M |
| April 02, 2024 | 71.38M |
| April 01, 2024 | 71.15M |
| March 28, 2024 | 71.14M |
| March 27, 2024 | 75.59M |
| March 26, 2024 | 75.92M |
| Date | Value |
|---|---|
| March 25, 2024 | 66.51M |
| March 22, 2024 | 62.47M |
| March 21, 2024 | 59.41M |
| March 20, 2024 | 59.74M |
| March 19, 2024 | 57.93M |
| March 18, 2024 | 57.35M |
| March 15, 2024 | 56.19M |
| March 14, 2024 | 55.62M |
| March 13, 2024 | 58.67M |
| March 12, 2024 | 55.12M |
| March 11, 2024 | 56.36M |
| March 08, 2024 | 59.50M |
| March 07, 2024 | 59.91M |
| March 06, 2024 | 55.04M |
| March 05, 2024 | 56.19M |
| March 04, 2024 | 53.47M |
| March 01, 2024 | 50.09M |
| February 29, 2024 | 52.48M |
| February 28, 2024 | 50.69M |
| February 27, 2024 | 51.78M |
| February 26, 2024 | 49.94M |
| February 23, 2024 | 49.11M |
| February 22, 2024 | 50.11M |
| February 21, 2024 | 52.76M |
| February 20, 2024 | 53.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.34M
Minimum
Mar 28 2023
115.67M
Maximum
Sep 02 2021
60.23M
Average
57.76M
Median
Sep 04 2020
Enterprise Value Benchmarks
| American Shared Hospital Services | 26.82M |
| Novo Integrated Sciences Inc | 13.96M |
| Astrana Health Inc | 1.444B |
| P3 Health Partners Inc | 427.64M |
| Biote Corp | 215.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.5562M |
| Revenue (Quarterly) | 7.852M |
| Total Expenses (Quarterly) | 7.036M |
| EPS Diluted (Quarterly) | 0.0674 |
| Gross Profit Margin (Quarterly) | 72.49% |
| Profit Margin (Quarterly) | 7.08% |
| Earnings Yield | -13.99% |
| Operating Earnings Yield | 4.04% |
| Normalized Earnings Yield | 1.811 |